The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats

Journal of Endocrinology

Volumn 165, Issue 3, 2000, Pages 569-577

  Svensson, J ^a   Lall, S ^b   Dickson, S L ^b   Bengtsson, B A ^a   Romer J ^c   Ahnfelt Ronne I ^c   Ohlsson, C ^a   Jansson, J O ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE DERIVATIVE; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; HUMAN GROWTH HORMONE; IPAMORELIN;

ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE MINERALIZATION; CONTROLLED STUDY; CORTICAL BONE; FEMALE; FEMUR; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; TIBIA; VERTEBRA;

EID: 0034131217     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1650569     Document Type: Article

References (38)

1. Andreassen T, Jørgensen P, Flyvberg A, Ørskov H & Oxlund H 1995 Growth hormone stimulates bone formation and strength of cortical bone in aged rats. Journal of Bone and Mineral Research 10 1057-1067.
2. Andreassen T, Melsen F & Oxlund H 1996 The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats. Journal of Bone and Mineral Research 11 1094-1102.
3. Ankersen M, Johansen NL, Madsen K, Hansen BS, Raun K, Nielsen KK, Thøgersen H, Hansen TK, Peschke B, Lau J, Lundt BF & Andersen PH 1998 A new series of highly potent growth hormone-releasing peptides derived from ipamorelin. Journal of Medicinal Chemistry 41 3699-3704.
4. Bateman TA, Zimmerman RJ, Ayers RA, Ferguson VL, Chapes SK & Simske SJ 1998 Histomorphometric, physical, and mechanical effects of spaceflight and insulin-like growth factor-I on rat long bones. Bone 23 527-535.
5. Bouillon R 1991 Growth hormone and bone. Hormonal Research 36 49-55.
6. Bowers CY, Momany FA, Reynolds GA & Hong A 1984 On the in vitro and the in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114 1537-1545.
7. Dickson SL & Luckman SM 1997 Induction of c-fos mRNA in NPY and GRF neurones in the rat arcuate nucleus following systemic injection of the growth hormone secretagogue, GHRP-6. Endocrinology 138 771-777.
8. Eriksen E, Kassem M & Langdahl B 1996 Growth hormone, insulin-like growth factors and bone remodelling. European Journal of Clinical Investigation 26 525-534.
9. Frohman L & Jansson J-O 1986 Growth hormone-releasing hormone. Endocrine Reviews 7 223-253.
10. Guillaume V, Magnan E, Cataldi M, Dutour A, Sauze N, Renard M, Razafindraibe H, Conte-Devolx B, Deghenghi R, Lenaerts V & Oliver C 1994 Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 135 1073-1076.
11. Hansen TK, Ankersen M, Hansen BS, Raun K, Nielsen KK, Lau J, Peschke B, Lundt BF, Thøgersen H, Johansen NL, Madsen K & Andersen PH 1998 Novel orally-active growth-hormone secretagogues. Journal of Medicinal Chemistry 41 3705-3714.
12. Howard A, Feighner S, Cully D, Arena J, Liberator P, Rosenblum C, Hamelin M, Hrenluk D, Palyha O, Anderson J, Paress P, Diaz C, Chou M, Liu K, McKee K, Pong S-S, Chaung L-Y, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirininathsingji D, Dean D, Melillo D, Patchett A, Nargund R, Griffin P, Demartino J, Gupta S, Schaeffer J, Smith R & Van der Ploeg L 1996 A pituitary gland and hypothalamic receptor that functions in growth hormone release. Science 273 974-977.
13. Huhn W, Hartmann M, Pezzoli S & Thorner M 1993 Twenty-four hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion, and specifically attenuates the response to a subsequent GHRP bolus. Journal of Clinical Endocrinology and Metabolism 76 1202-1208.
14. Jaffe C, Ho P, Demott-Friberg R, Bowers C & Barkan A 1993 Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. Journal of Clinical Endocrinology and Metabolism 77 1641-1647.
15. Johannsson G, Rosén T, Bosaeus I, Sjöström L & Bengtsson B-Å 1996 Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. Journal of Clinical Endocrinology and Metabolism 81 2865-2873.
16. Jørgensen P, Bak B & Andreassen T 1991 Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormone. Bone 12 353-359.
17. Kassem M, Blum W, Ristelli J, Mosekilde L & Eriksen E 1993 Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcified Tissue International 52 222-226.
18. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach (Letter). Nature 402 656-660.
19. Laron Z, Frenkel J, Deghengbi R, Anin S, Klinger B & Sibergeld A 1995 Intranasal administration of the GHRP hexarelin accelerates growth in short children. Clinical Endocrinology 43 631-635.
20. Locke W, Kirgis H, Bowers C & Abdoh A 1995 Intracerebroventricular growth hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats. Life Sciences 56 1347-1352.
21. Mericq V, Cassorla F, Salazar T, Avila A, Iniguez G, Bowers C & Merriam G 1998 Effects of eight months treatment with graded doses of a growth hormone (GH)-releasmg peptide in GH-deficient children. Journal of Clinical Endocrinology and Metabolism 83 2355-2360.
22. Nilsson A, Swolin D, Enerbäck S & Ohlsson C 1995 Expression of functional growth hormone receptors in cultured human osteoblast-like cells. Journal of Clinical Endocrinology and Metabolism 80 3483-3488.
23. Ohlsson C, Bengtsson B-Å, Isaksson O, Andreassen T & Slootweg M 1998 Growth hormone and bone. Endocrine Reviews 19 55-79.
24. Okada K, Ishii S, Minami S, Sugihara H, Shibasaki T & Wakabayashi I 1996 Intraventricular administration of the growth hormone releasing peptide KP-102 increases food intake in free-feeding rats. Endocrinology 137 5155-5158.
25. Ong H, McNicoll N, Escher E, Collu R, Deghenghi R, Locatelli V, Ghigo E, Muccioli G, Boghen M & Nilsson M 1998 Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling. Endocrinology 139 432-435.
26. Oscarsson J, Johannsson G, Johansson J-O, Lundberg P-A, Lindstedt G & Bengtsson B-Å 1997 Diurnal variation in serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults. Clinical Endocrinology 46 63-68.
27. Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M & Andersen PH 1998 Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology 139 552-561.
28. Rosen H, Chen V, Cittadini A, Greenspan S, Douglas P, Moses A & Beamer W 1995 Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density. Journal of Bone and Mineral Research 10 1352-1358.
29. Sandstedt J, Törnell J, Norjavaara E, Isaksson OGP & Ohlsson C 1996 Elevated levels of growth hormone increase bone mineral content in normal young mice, but not in ovariectomized mice. Endocrinology 137 3368-3374.
30. Sass D, Jerome C, Bowman A, Bennett-Cain A, LeRoith D & Epstein S 1997 Short term effects of GH and IGF-1 on cancellous bone formation in rhesus macaque monkeys. Journal of Clinical Endocrinology and Metabolism 82 1202-1209.
31. Smith R, Van Der Ploeg L, Howard A, Feighner S, Cheng K, Hickey G, Wyvratt MJ, Fischer M, Nargund R & Patchett A 1998 Peptidomimetic regulation of growth hormone secretion. Endocrine Reviews 18 621-645.
32. Svensson J, Lönn L, Jansson J-O, Murphy G, Wyss D, Krupa D, Cerchio K, Polvino W, Gertz B, Boseaus I, Sjöström L & Bengtsson B-Å 1998a Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. Journal of Clinical Endocrinology and Metabolism 83 362-369.
33. Svensson J, Ohlsson C, Jansson J-O, Murphy G, Wyss D, Krupa D, Cerchio K, Polvino W, Gertz B, Baylink D, Mohan S & Bengtsson B-Å 1981b Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males. Journal of Bone and Mineral Research 13 1158-1166.
34. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamagushi A, Moseley J, Martin T & Suda T 1988 Osteoblastic cells are involved in osteoclast formation. Endocrinology 123 2600-2602.
35. Turner R 1995 Effects of short-term space-flight and recombinant human growth hormone (rhGH) on bone growth in young rats. Aviation, Space, and Environmental Medicine 66 763-769.
36. Verrat-Durebex C, Gaudreau P, Coxam V, Gaumet N & Alliot J 1999 Peripheral injection of growth hormone stimulates protein intake in aged male and female Lou rats. American Journal of Physiology 276 E1105-E1111.
37. Windahl SH, Vidal O, Andersson G, Gustafsson JÅ & Ohlsson C 1999 Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta (-/ -) mice. Journal of Clinical Investigation 104 895-901.
38. Yeh J, Aloia J & Chen M 1994 Growth hormone administration potentiates the effect of treadmill exercise on long bone formation but not on the vertebrae in middle-aged rats. Calcified Tissue International 54 38-43.